MedStorm Innovation

www.med-storm.com

MedStorm offers a unique solution to improve the quality of pain management and daily workload in the wards. Pain is treated as the fifth vital sign, emphasizing the importance of high-quality pain management. The use of MedStorm's PainMonitor can, among others, tailor the need for analgesia, reduce side effects from over- and under sedation, as well as reducing the length of stay and therefore also costs for the hospitals. Our real-time PainMonitor device is based on skin conductance changes during anaesthesia, intensive care, postoperatively and in preterm infants. Additionally, the device has indices for assessing awakening, withdrawal symptoms, and the effect of regional nerve-block within seconds. Our technology is based on 20 years of medical research, and there are more than 70 supportive validation studies and 3 theses, see https://med-storm.com/clinical/references/. All studies show that the index increases during pain and nociceptive stimuli, and may predict painful events more sensitively and specifically than other available tools in all age groups. Moreover, the index decreases when analgesia is given. The index reacts within seconds, has low variation between and within individuals, and has higher accuracy to assess pain responses as compared to current methods. For more information about our technology, visit https://med-storm.com/ or contact us at support@med-storm.com.

Read more

Reach decision makers at MedStorm Innovation

Lusha Magic

Free credit every month!

MedStorm offers a unique solution to improve the quality of pain management and daily workload in the wards. Pain is treated as the fifth vital sign, emphasizing the importance of high-quality pain management. The use of MedStorm's PainMonitor can, among others, tailor the need for analgesia, reduce side effects from over- and under sedation, as well as reducing the length of stay and therefore also costs for the hospitals. Our real-time PainMonitor device is based on skin conductance changes during anaesthesia, intensive care, postoperatively and in preterm infants. Additionally, the device has indices for assessing awakening, withdrawal symptoms, and the effect of regional nerve-block within seconds. Our technology is based on 20 years of medical research, and there are more than 70 supportive validation studies and 3 theses, see https://med-storm.com/clinical/references/. All studies show that the index increases during pain and nociceptive stimuli, and may predict painful events more sensitively and specifically than other available tools in all age groups. Moreover, the index decreases when analgesia is given. The index reacts within seconds, has low variation between and within individuals, and has higher accuracy to assess pain responses as compared to current methods. For more information about our technology, visit https://med-storm.com/ or contact us at support@med-storm.com.

Read more
icon

Country

icon

City (Headquarters)

Oslo

icon

Employees

11-50

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Technology Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Member of the Board of Advisors

    Email ****** @****.com
    Phone (***) ****-****
  • Clinical Manager

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(11)

Reach decision makers at MedStorm Innovation

Free credits every month!

My account

Sign up now to uncover all the contact details